Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma

Mantle cell lymphoma (MCL) is a clinically heterogeneous B cell malignancy for which a variety of prognostic factors have been proposed. Previously, a digital gene expression profiling “proliferation signature” capable of risk stratifying MCL was identified and subsequently developed into a multi-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsower, Colleen A., Maguire, Alanna, Robetorye, Ryan S., Feldman, Andrew L., Syrbu, Sergei I., Rosenthal, Allison C., Rimsza, Lisa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661397/
https://www.ncbi.nlm.nih.gov/pubmed/33193905
http://dx.doi.org/10.1007/s12308-020-00418-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661397/
https://www.ncbi.nlm.nih.gov/pubmed/33193905
http://dx.doi.org/10.1007/s12308-020-00418-4

Ejemplares similares